Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
出版年份 2020 全文链接
标题
Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
作者
关键词
-
出版物
CANCER AND METASTASIS REVIEWS
Volume 38, Issue 4, Pages 625-642
出版商
Springer Science and Business Media LLC
发表日期
2020-01-23
DOI
10.1007/s10555-019-09839-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rhabdomyosarcoma
- (2019) Stephen X. Skapek et al. Nature Reviews Disease Primers
- USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth
- (2019) Maria E. Gierisch et al. Scientific Reports
- Targeting the IGF1R/PI3K/AKT pathway sensitizes Ewing sarcoma to BET bromodomain inhibitors
- (2019) Sudan N Loganathan et al. MOLECULAR CANCER THERAPEUTICS
- Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner
- (2019) Matt L. Harlow et al. CLINICAL CANCER RESEARCH
- Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis
- (2019) Carla De Giovanni et al. BMC CANCER
- INFORM2 exploratory multinational phase I/II combination study of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies: INFORM2 NivEnt.
- (2019) Cornelis Martinus van Tilburg et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis
- (2019) Yan Ma et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Immunogenic neoantigens derived from gene fusions stimulate T cell responses
- (2019) Wei Yang et al. NATURE MEDICINE
- Evaluation of entinostat alone and in combination with standard‐of‐care cytotoxic agents against rhabdomyosarcoma xenograft models
- (2019) Raushan T. Kurmasheva et al. PEDIATRIC BLOOD & CANCER
- EWS–FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex
- (2019) Saravana P Selvanathan et al. NUCLEIC ACIDS RESEARCH
- Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines
- (2019) Darcy Welch et al. PLoS One
- Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
- (2019) Julian Musa et al. Nature Communications
- The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma
- (2018) Matthew J. McBride et al. CANCER CELL
- The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma
- (2018) Ana Banito et al. CANCER CELL
- Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases
- (2018) Giuliana Cassinelli et al. CANCER LETTERS
- EWS/ETS-driven Ewing Sarcoma requires BET bromodomain proteins
- (2018) Paradesi Naidu Gollavilli et al. CANCER RESEARCH
- Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas
- (2018) Sarina Gouravan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synovial Sarcoma: Current Concepts and Future Perspectives
- (2018) Silvia Stacchiotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway
- (2018) Haim Werner et al. Molecular Cancer
- Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma
- (2018) Bárbara Kunzler Souza et al. MOLECULAR NEUROBIOLOGY
- Epigenome-based cancer risk prediction: rationale, opportunities and challenges
- (2018) Martin Widschwendter et al. Nature Reviews Clinical Oncology
- Ewing sarcoma
- (2018) Thomas G. P. Grünewald et al. Nature Reviews Disease Primers
- Epigenome editing of microsatellite repeats defines tumor-specific enhancer functions and dependencies
- (2018) Gaylor Boulay et al. GENES & DEVELOPMENT
- ADVL1513: Results of a phase 1 trial of entinostat, an oral histone deacetylase inhibitor, in pediatric patients with recurrent or refractory solid tumors.
- (2018) Suman Malempati et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of lurbinectedin (PM1183) in Ewing sarcoma: Final results from a phase 2 study.
- (2018) Vivek Subbiah et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical Evaluation of Nintedanib, a Triple Angiokinase Inhibitor, in Soft-Tissue Sarcoma: Potential Therapeutic implication for Synovial Sarcoma
- (2018) Parag P Patwardhan et al. MOLECULAR CANCER THERAPEUTICS
- Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors
- (2018) Nathaniel D. Anderson et al. SCIENCE
- The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
- (2018) Daniel Jose García-Domínguez et al. Oncotarget
- A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
- (2018) Lillian M. Guenther et al. CLINICAL CANCER RESEARCH
- A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation
- (2018) Brittany C. Michel et al. NATURE CELL BIOLOGY
- The HDAC3–SMARCA4–miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma
- (2018) Narendra Bharathy et al. Science Signaling
- Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
- (2018) Gerard L Brien et al. eLife
- Canonical WNT/β-Catenin Signaling Plays a Subordinate Role in Rhabdomyosarcomas
- (2018) Nada Ragab et al. Frontiers in Pediatrics
- SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis
- (2017) Changliang Peng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma
- (2017) Puspa R Pandey et al. JOURNAL OF PATHOLOGY
- Death by HDAC Inhibition in Synovial Sarcoma Cells
- (2017) Aimée N. Laporte et al. MOLECULAR CANCER THERAPEUTICS
- Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene
- (2017) Zhang-Hui Chen et al. NATURE BIOTECHNOLOGY
- Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
- (2017) Alison M. Schram et al. Nature Reviews Clinical Oncology
- Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells
- (2017) G-A Franzetti et al. ONCOGENE
- Exosomes: Therapy delivery tools and biomarkers of diseases
- (2017) Lucio Barile et al. PHARMACOLOGY & THERAPEUTICS
- Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma
- (2017) Kirsten M. Johnson et al. PLoS One
- Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth
- (2017) Kirsten M. Johnson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
- (2017) Berkley E. Gryder et al. Cancer Discovery
- Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma
- (2017) Masanori Hayashi et al. Oncotarget
- The neoepitope landscape in pediatric cancers
- (2017) Ti-Cheng Chang et al. Genome Medicine
- CRISPR/Cas9 in Genome Editing and Beyond
- (2016) Haifeng Wang et al. Annual Review of Biochemistry
- Coinhibitory Pathways in Immunotherapy for Cancer
- (2016) Susanne H. Baumeister et al. Annual Review of Immunology
- Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus
- (2016) Matt L. Harlow et al. CANCER RESEARCH
- Activation of Wnt/ -Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States
- (2016) E. A. Pedersen et al. CANCER RESEARCH
- Vorinostat in refractory soft tissue sarcomas – Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO)
- (2016) Thomas Schmitt et al. EUROPEAN JOURNAL OF CANCER
- Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue
- (2016) Maria E. Gierisch et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells
- (2016) Vittorio Caropreso et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RGD liposome-protamine-siRNA (LPR) nanoparticles targeting PAX3-FOXO1 for alveolar rhabdomyosarcoma therapy
- (2016) Venkatesh Rengaswamy et al. JOURNAL OF CONTROLLED RELEASE
- The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
- (2016) H. K. Bid et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma
- (2016) Donald D. Rao et al. MOLECULAR THERAPY
- Chinese scientists to pioneer first human CRISPR trial
- (2016) David Cyranoski NATURE
- Driving CAR T-cells forward
- (2016) Hollie J. Jackson et al. Nature Reviews Clinical Oncology
- Targeting the cancer epigenome for therapy
- (2016) Peter A. Jones et al. NATURE REVIEWS GENETICS
- EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma
- (2016) F Cidre-Aranaz et al. ONCOGENE
- Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program
- (2016) Raushan T. Kurmasheva et al. PEDIATRIC BLOOD & CANCER
- Panobinostat-A Potential Treatment for Metastasized Ewing Sarcoma? A Case Report
- (2016) Annemiek M. van Maldegem et al. PEDIATRIC BLOOD & CANCER
- CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases
- (2016) Faheem Ahmed Khan et al. Oncotarget
- Advances in sarcoma diagnostics and treatment
- (2016) Amanda R. Dancsok et al. Oncotarget
- Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
- (2016) Camille Jacques et al. Oncotarget
- Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma
- (2016) Changliang Peng et al. Oncotarget
- The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma
- (2016) Luisa Cironi et al. Scientific Reports
- Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitro
- (2016) Jacson K. Shen et al. Scientific Reports
- A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas—NCIC-CTG IND 200†
- (2015) Q. S.-C. Chu et al. ANNALS OF ONCOLOGY
- SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma
- (2015) S.-W. Tang et al. CLINICAL CANCER RESEARCH
- Targeting hedgehog signalling by arsenic trioxide reduces cell growth and induces apoptosis in rhabdomyosarcoma
- (2015) KAREN A. BOEHME et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
- (2015) Thomas G P Grünewald et al. NATURE GENETICS
- RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1
- (2015) Hayriye Verda Erkizan et al. NUCLEIC ACIDS RESEARCH
- Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing
- (2015) Saravana P. Selvanathan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma
- (2015) Ulrike Graab et al. Oncotarget
- The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
- (2015) José Luis Ordóñez et al. Oncotarget
- Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options
- (2015) J M Loupe et al. Oncogenesis
- IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma
- (2015) Xiaolin Wan et al. NEOPLASIA
- EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma
- (2015) Florencia Cidre-Aranaz et al. Frontiers in Oncology
- GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis
- (2015) Ritesh K. Srivastava et al. Oncotarget
- A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance
- (2014) Alberto S. Pappo et al. CANCER
- PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
- (2014) V. Thalhammer et al. CANCER RESEARCH
- Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth
- (2014) S. Sankar et al. CLINICAL CANCER RESEARCH
- Lineage of origin in rhabdomyosarcoma informs pharmacological response
- (2014) J. Abraham et al. GENES & DEVELOPMENT
- Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation
- (2014) Friederike Itzen et al. NUCLEIC ACIDS RESEARCH
- The landscape and therapeutic relevance of cancer-associated transcript fusions
- (2014) K Yoshihara et al. ONCOGENE
- Regulation of FAS Exon Definition and Apoptosis by the Ewing Sarcoma Protein
- (2014) Maria Paola Paronetto et al. Cell Reports
- Classification of Rhabdomyosarcoma and Its Molecular Basis
- (2013) David M. Parham et al. ADVANCES IN ANATOMIC PATHOLOGY
- A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
- (2013) P A Cassier et al. BRITISH JOURNAL OF CANCER
- SRC Signaling Is Crucial in the Growth of Synovial Sarcoma Cells
- (2013) S. Michels et al. CANCER RESEARCH
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma
- (2013) Cigall Kadoch et al. CELL
- Loss of SS18-SSX1 Inhibits Viability and Induces Apoptosis in Synovial Sarcoma
- (2013) Emily E. Carmody Soni et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: A rational choice
- (2013) J. Carlijn van Gaal et al. EUROPEAN JOURNAL OF CANCER
- Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma
- (2013) Srinivas R Annavarapu et al. LABORATORY INVESTIGATION
- Small Molecule Inhibition of PAX3-FOXO1 through AKT Activation Suppresses Malignant Phenotypes of Alveolar Rhabdomyosarcoma
- (2013) M. Jothi et al. MOLECULAR CANCER THERAPEUTICS
- Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma
- (2013) Srikanth R. Ambati et al. Molecular Oncology
- Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis
- (2013) Gautier Stoll et al. NUCLEIC ACIDS RESEARCH
- Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma
- (2013) Z Kang et al. ONCOGENE
- The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx)
- (2013) R Ciarapica et al. ONCOGENE
- SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma
- (2013) M Trautmann et al. ONCOGENE
- JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
- (2013) Z S Walters et al. ONCOGENE
- Cetuximab promotes anticancer drug toxicity in rhabdomyosarcomas with EGFR amplification in vitro
- (2013) YUKI YAMAMOTO et al. ONCOLOGY REPORTS
- Cyclin-Dependent Kinase 4 Phosphorylates and Positively Regulates PAX3-FOXO1 in Human Alveolar Rhabdomyosarcoma Cells
- (2013) Lingling Liu et al. PLoS One
- Targeting the Wnt Pathway in Synovial Sarcoma Models
- (2013) W. Barham et al. Cancer Discovery
- An adaptive Src–PDGFRA–Raf axis in rhabdomyosarcoma
- (2012) Jinu Abraham et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR–dependent motility in alveolar rhabdomyosarcoma cells
- (2012) Lingling Liu et al. BMC CANCER
- Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing Family Tumors
- (2012) Yan Li et al. CANCER LETTERS
- Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC- Abolishes Ewing Sarcoma Growth
- (2012) D. Surdez et al. CANCER RESEARCH
- AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell
- (2012) Mathivanan Jothi et al. CELL CYCLE
- EWS-FLI-1-Targeted Cytotoxic T-cell Killing of Multiple Tumor Types Belonging to the Ewing Sarcoma Family of Tumors
- (2012) C. H. Evans et al. CLINICAL CANCER RESEARCH
- FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma
- (2012) L. E. S. Crose et al. CLINICAL CANCER RESEARCH
- A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report
- (2012) B. C. Widemann et al. CLINICAL CANCER RESEARCH
- Evaluation of arsenic trioxide by the pediatric preclinical testing program with a focus on Ewing sarcoma
- (2012) Malcolm A. Smith et al. PEDIATRIC BLOOD & CANCER
- Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity
- (2012) Silke Schlottmann et al. Frontiers in Oncology
- CAPER-α alternative splicing regulates the expression of vascular endothelial growth factor165 in Ewing sarcoma cells
- (2011) Gangxiong Huang et al. CANCER
- Hedgehog signal inhibitor forskolin suppresses cell proliferation and tumor growth of human rhabdomyosarcoma xenograft
- (2011) Hiroaki Yamanaka et al. JOURNAL OF PEDIATRIC SURGERY
- Prevalence and prognostic influence of genomic changes of EGFR pathway markers in synovial sarcoma
- (2011) Hao-Wei Teng et al. JOURNAL OF SURGICAL ONCOLOGY
- The Effect of SYT-SSX and Extracellular Signal-Regulated Kinase (ERK) on Cell Proliferation in Synovial Sarcoma
- (2011) Wenjuan Cai et al. PATHOLOGY & ONCOLOGY RESEARCH
- Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma
- (2010) M Eichenmüller et al. BRITISH JOURNAL OF CANCER
- Sorafenib induces growth inhibition and apoptosis in human synovial sarcoma cells via inhibiting the RAF/MEK/ERK signaling pathway
- (2010) Chang-Liang Peng et al. CANCER BIOLOGY & THERAPY
- Inhibition of the transcriptional function of p53 by EWS–Fli1 chimeric protein in Ewing Family Tumors
- (2010) Yan Li et al. CANCER LETTERS
- Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer
- (2010) L. Cao et al. CANCER RESEARCH
- Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model
- (2010) Iori Takigami et al. INTERNATIONAL JOURNAL OF CANCER
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment
- (2010) R M Hecker et al. ONCOGENE
- Synovial Sarcoma is a Stem Cell Malignancy
- (2010) Norifumi Naka et al. STEM CELLS
- Glycogen synthase kinase 3 regulates PAX3–FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells
- (2009) Fu-Yue Zeng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ewing Sarcoma Fusion Protein EWSR1/FLI1 Interacts with EWSR1 Leading to Mitotic Defects in Zebrafish Embryos and Human Cell Lines
- (2009) L. J. Embree et al. CANCER RESEARCH
- GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
- (2009) Elspeth Beauchamp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brd4 Marks Select Genes on Mitotic Chromatin and Directs Postmitotic Transcription
- (2009) Anup Dey et al. MOLECULAR BIOLOGY OF THE CELL
- A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma
- (2009) Hayriye V Erkizan et al. NATURE MEDICINE
- O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma
- (2009) R Bachmaier et al. ONCOGENE
- EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
- (2009) G. H. S. Richter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Differential roles of SS18–SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth
- (2008) Maria Törnkvist et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phosphorylation of Ewing's sarcoma protein (EWS) and EWS-Fli1 in response to DNA damage
- (2008) Iva V. Klevernic et al. BIOCHEMICAL JOURNAL
- Alveolar rhabdomyosarcoma: Is the cell of origin a mesenchymal stem cell?
- (2008) Elizabeth Charytonowicz et al. CANCER LETTERS
- Phosphorylation Regulates Transcriptional Activity of PAX3/FKHR and Reveals Novel Therapeutic Possibilities
- (2008) R. Amstutz et al. CANCER RESEARCH
- Histone Deacetylase Inhibitors Reverse SS18-SSX-Mediated Polycomb Silencing of the Tumor Suppressor Early Growth Response 1 in Synovial Sarcoma
- (2008) J. M. Lubieniecka et al. CANCER RESEARCH
- The Oncoprotein SS18-SSX1 Promotes p53 Ubiquitination and Degradation by Enhancing HDM2 Stability
- (2008) P. D'Arcy et al. MOLECULAR CANCER RESEARCH
- Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer
- (2008) G. Sanchez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microsatellites as EWS/FLI response elements in Ewing's sarcoma
- (2008) K. Gangwal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of proteins interacting with protein arginine methyltransferase 8: The Ewing sarcoma (EWS) protein binds independent of its methylation state
- (2008) Steffen Pahlich et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma
- (2007) Ken Kikuchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now